NCT01968395View on ClinicalTrials.gov

Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

October 21, 2014

Conditions
Bacterial Infections and MycosesLiver Disease
Interventions
DRUG

Caspofungin 70 mg

Intravenous use

Trial Locations (1)

1070

Erasme University Hospital, Brussels

All Listed Sponsors
lead

Erasme University Hospital

OTHER

NCT01968395 - Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure | Biotech Hunter | Biotech Hunter